Overview of cellular immunotherapy for patients with glioblastoma. - Wikidata - wikimedia - TriplyDB

Overview of cellular immunotherapy for patients with glioblastoma.

Overview of cellular immunotherapy for patients with glioblastoma.

http://www.wikidata.org/entity/Q34189694

about

CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas The progress of immunotherapy for glioblastoma Clinical application of adoptive T cell therapy in solid tumors Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials Prospects of immune checkpoint modulators in the treatment of glioblastoma Multidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma.Immune genes are associated with human glioblastoma pathology and patient survival.Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells.Novel therapies in glioblastoma.Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model Safety profile of gutless adenovirus vectors delivered into the normal brain parenchyma: implications for a glioma phase 1 clinical trial Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors.Advances in Immunotherapy for Glioblastoma Multiforme.Passive immunotherapeutic strategies for the treatment of malignant gliomas.Mechanisms of immunomodulation in human glioblastoma.Immunotherapy for the treatment of glioblastoma.Immunotherapy for head and neck cancer patients: shifting the balance.Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours Glioblastoma multiforme: State of the art and future therapeutics.State of the art and perspectives in the treatment of glioblastoma.Vaccine-based immunotherapy for glioblastoma.Vaccine therapies for patients with glioblastoma.Current Studies of Immunotherapy on Glioblastoma Immunotherapeutic advancements for glioblastoma.Inhibition of Notch1 signaling overcomes resistance to the death ligand Trail by specificity protein 1-dependent upregulation of death receptor 5.Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas.Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma.Enhancement of glioma-specific immunity in mice by "NOBEL", an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide.Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.Whole tumor cell vaccines for glioma immunotherapy.

P2860

Q26740520-725108AF-25BB-497D-B00D-DB4F15E3DF82 Q26797282-9428CF22-6D62-4AFD-A058-5F72AA83595A Q27011283-68736341-7361-4DB7-B96B-F76D6F3EFB34 Q27014829-EAC40939-662C-4700-BB3E-FBD083FD3849 Q28081371-F0AA3401-8C0F-42B8-80A1-54C239DC1B83 Q31022597-DCED330C-3598-415F-B64F-F821F8BECFC0 Q34415093-A85157D7-7637-49A0-854D-8AE815A74582 Q34770719-BD3F5487-4422-4F8C-8E67-BEA5F88AF73F Q35145144-7EE50159-C60C-45B8-906F-D099D0E134B7 Q35835755-78BA36FE-370F-4C29-9662-DC669AA1DDA9 Q35864136-9A6FB564-67B6-4923-A29B-82662F76699F Q36231664-188EB916-7008-4851-8436-2A2C64B04EAF Q36345439-A5066080-BBBB-4BE2-9B13-345267A54804 Q36534329-66547146-7AF0-4D26-9CDF-0414404ABB4C Q36618229-3EE99C16-8738-404D-ACCE-37A7382DF502 Q37079078-13380E5C-FE51-40AB-B3FE-D5935D01B27E Q37680966-3F625B5B-627F-4F09-AB77-FC9010A049D1 Q37714783-A0F0BED4-A31E-44FE-8D78-6CEFC3118FA5 Q37869493-BA34DE38-1FEB-462C-9D3D-AC590AD0F573 Q37980026-65BB6C8A-B624-4C26-A09F-8664AC5C31D5 Q38068966-6D7C6134-ACCC-419C-9258-42C4977B057D Q38148501-F790E6E1-F921-49AC-8449-E421123B84AF Q38225874-53DAF4F9-306D-4ED5-A693-5EA7F4F0F5C9 Q38233067-2281CDE1-615F-4FC3-9D23-D9D9258EF318 Q38233114-FB51EAAF-A59E-4791-B7D2-B468051464AD Q38243975-52D06C9A-75F6-4F4F-8D06-AFE07A701FEB Q38262914-BD9FD81A-13EF-49F2-A983-92080BC29F29 Q38358124-3398913D-754C-44CB-B50A-A91FF5093635 Q38827688-E2F0B6EC-E93D-433C-854C-1FF64660FD3F Q38912265-2DA1A58D-D085-47A0-A9AD-613F74DFC0BD Q39208487-45216D24-5345-47C0-B076-FCBC3AAF9C69 Q41109977-067F929C-E99E-469A-90DE-E819242BE88A Q48379910-974AE5FD-8E16-4668-B6F5-1C09C840E131 Q48467671-1FE6EE23-EE45-40EA-BD47-973455591D24 Q53086671-EA45433A-843F-4035-8869-737FF70AC0CC

P2860

Overview of cellular immunotherapy for patients with glioblastoma.

http://www.wikidata.org/entity/Q34189694

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Overview of cellular immunotherapy for patients with glioblastoma.

@ast

Overview of cellular immunotherapy for patients with glioblastoma.

@en

Overview of cellular immunotherapy for patients with glioblastoma.

@nl

type

label

Overview of cellular immunotherapy for patients with glioblastoma.

@ast

Overview of cellular immunotherapy for patients with glioblastoma.

@en

Overview of cellular immunotherapy for patients with glioblastoma.

@nl

prefLabel

Overview of cellular immunotherapy for patients with glioblastoma.

@ast

Overview of cellular immunotherapy for patients with glioblastoma.

@en

Overview of cellular immunotherapy for patients with glioblastoma.

@nl

P1433

Q34189694-D2115AF5-A3BC-4424-B9A1-F41692921490

P1476

Q34189694-8A9B36B9-291A-43FA-ACF0-E010B778F1DE

P2093

Q34189694-1A206EA2-AD32-49B7-9418-5FD1F613A141

Q34189694-7643CCFD-139B-49E0-9E48-B7A5B305D25B

Q34189694-816C20EC-8241-46A8-953A-AD47C4A2D571

Q34189694-DE93D46E-BD66-48BE-B163-5E2C54308BF1

P275

Q34189694-0D0BDAC2-A078-4660-8EA1-80F81BAF17E7

P2860

Q34189694-01703F7B-B1A1-4CB0-A0E8-7F4A1716CC7B

Q34189694-02AA69A7-5632-4406-A084-C9203575C212

Q34189694-048DA5E4-1909-4BA0-B88A-EA751C02823D

Q34189694-073BF37E-2875-4A56-8B4F-338F11935B22

Q34189694-07B5F25F-001E-4F40-A59F-4BC312B0A56B

Q34189694-07F609A3-0725-4CC8-8AC7-2E784917BE3F

Q34189694-083B752B-089E-4EEC-B726-D447BE7518C0

Q34189694-08548152-8F4A-4222-8474-BA7E22F60B78

Q34189694-08C1051E-2FBD-4C29-A10D-AC4C9ADB61FC

Q34189694-09180173-F004-4BD5-99C3-A9400FC33C7D

P304

Q34189694-02661752-4A5D-4D01-8903-0AB564A77267

P31

Q34189694-06DFEE91-256D-4125-9783-B83F2E11D4C4

P356

Q34189694-79E97753-75F5-42C8-9024-10B8D519831D

P478

Q34189694-44F1133B-38B1-4AAB-B979-4F53426AA208

P50

Q34189694-D551AF91-13E9-4D0B-85C7-1167005106A0

P5008

Q34189694-9B61FB4C-B68E-4E63-A25A-BC099895AFE1

P577

Q34189694-F11DBA7E-0B26-49FF-BC5A-79F7B92D42C4

P5875

Q34189694-C55F3E97-234F-4733-95B2-E12B120B17EF

P698

Q34189694-1A488E37-90A5-4070-A990-97F08AD650E2

P921

Q34189694-0B48CCDA-0422-4A0F-8E51-EA105937E14E

Q34189694-3248C760-A2EB-4D06-8773-A8ED7002A164

Q34189694-41E6B9AC-0B97-4854-8875-83001842BCA4

Q34189694-41FA7F9A-5E4C-44B3-B1B7-66402134D52D

Q34189694-74834FB4-2A25-4827-AFFA-8635703CD10C

Q34189694-E51A3E7D-2FEF-4256-88D6-1B7B884AA73E

P932

Q34189694-447B3909-06B8-44F0-99D5-E631A1E0BC8A

P356

P1433

Clinical and Developmental Immunology

P1476

Overview of cellular immunotherapy for patients with glioblastoma

@en

P2093

Brigitte Collet

http://www.w3.org/2001/XMLSchema#string

Elodie Vauleon

http://www.w3.org/2001/XMLSchema#string

Jean Mosser

http://www.w3.org/2001/XMLSchema#string

Tony Avril

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Cancer immunotherapy: moving beyond current vaccines

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Myeloid-derived suppressor cells as regulators of the immune system

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial

Immunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model.

Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10.

Trafficking of immune cells in the central nervous system

The WHO classification of tumors of the nervous system.

Immune defects observed in patients with primary malignant brain tumors.

P304

742-751

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/689171

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P50

Véronique Quillien

P5008

P577

2010-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47450596

http://www.w3.org/2001/XMLSchema#string

P698

20953324

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

2952949

http://www.w3.org/2001/XMLSchema#string